Biodesix, in partnership with Bio-Rad and Thermo Fisher Scientific, advances tumor-informed and tumor-naïve MRD assays for ...

A study finds permissive lab screening thresholds double primary aldosteronism detection rates versus Endocrine Society ...

Illumina has introduced three early-access software capabilities on its BioInsight Platform designed to automate informatics ...

Gene by Gene will provide whole-genome sequencing for Children’s Mercy’s program, targeting nearly 100,000 pediatric genomes.

WHO grants Emergency Use Listing to BioFire’s Global Fever Special Pathogens Panel, enabling rapid detection of Ebola and 15 ...

Diadem receives a US patent expanding protection for its AlzoSure Predict blood assay, which detects U-p53AZ, a biomarker ...

Biodesix and Vanderbilt are developing an AI-driven lung cancer risk test combining blood-based and imaging biomarkers.

Ultima Genomics’ UG200 Platform will support an 80,000-sample UK Biobank immune profiling study with IMU Biosciences.

A Penn State-led team developed a rapid syphilis test that detects low antibody titers in one step, with up to 46% stronger ...

The companies will collaborate with AstraZeneca to advance local lab testing for a prostate cancer genomic instability ...

Beckman Coulter Diagnostics appoints Catherine Jennings, formerly of Boston Scientific as president to lead global operations ...

Keck Medicine of USC has begun a trial to assess a blood test for early breast cancer detection, evaluating its use alongside ...